[EN] PROTEASE ACTIVATED RECEPTOR 2 (PAR2) ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR 2 ACTIVÉ PAR DES PROTÉASES (PAR2)
申请人:PROXIMAGEN LTD
公开号:WO2012101453A1
公开(公告)日:2012-08-02
A compound of formula (I) or a pharmaceutically acceptable salt, solvate, hydrate thereof (I) Wherein Y, Z, R3, U, R4, m and n are as defined in the claims.
A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrate thereof
Wherein Y, Z, R
3
, U, R
4
, m and n are as defined in the claims.
The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.